Cellular Dynamics International (ICEL) Receiving Somewhat Positive Media Coverage, Study Finds
News articles about Cellular Dynamics International (NASDAQ:ICEL) have trended somewhat positive on Thursday, Accern Sentiment reports. The research group scores the sentiment of media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Cellular Dynamics International earned a media sentiment score of 0.22 on Accern’s scale. Accern also gave news stories about the company an impact score of 43.6881677354836 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
Shares of Cellular Dynamics International (ICEL) opened at 16 on Thursday. Cellular Dynamics International has a one year low of $5.00 and a one year high of $17.00. The stock has a 50 day moving average of $14.00 and a 200-day moving average of $8.00.
About Cellular Dynamics International
Cellular Dynamics International, Inc develops and produces functioning human cells in industrial quantities. The Company’s products include true human cells in multiple cell types (iCell products), human induced pluripotent stem cells (iPSCs) and custom iPSCs and iCell products (MyCell products). It markets its products for use in life science in vitro research and development, as well as applied product testing, stem cell banking and in vivo cellular therapeutics.
Receive News & Stock Ratings for Cellular Dynamics International Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellular Dynamics International Inc and related stocks with our FREE daily email newsletter.